Evidence map›Paper›PMID 41892978›Full record

ArticleMarine drugs2026

A λ-Carrageenan-Enriched Sulfated Galactan from

Kexin Du, Shuo Liang, Zijing Wu, Yujing Wang, Pengcheng Gao, Wei Han, Youjing Lv, Guangli Yu, Guoyun Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Bioactive Sulfated Polysaccharides from Green AlgaeInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kexin DuKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Shuo LiangKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Zijing WuKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Yujing WangKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Pengcheng GaoKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Wei HanQingdao Key Laboratory of Respiratory Comorbidity Remodeling and Precision Prevention, Qingdao Municipal Hospital, Qingdao 260071, China.
Youjing LvKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Guangli YuKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.ORCID 0000-0002-6372-9750
Guoyun LiKey Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease driven by immune dysregulation and epidermal barrier dysfunction. Current therapeutic options are often limited by safety concerns or suboptimal tolerability. In this study, we isolated and structurally characterized GRB-H-a λ-carrageenan-enriched sulfated hybrid galactan from the marine red alga

Indexed as

Anti-Inflammatory AgentsCarrageenanDermatitis, AtopicGalactansImmunomodulating AgentsRhodophytaAnimalsCytokinesDinitrochlorobenzeneDisease Models, AnimalFemaleHaCaT CellsHumansMaleMiceMice, Inbred BALB CAnti-Inflammatory AgentsCarrageenanCytokinesDinitrochlorobenzeneGalactansImmunomodulating AgentsSulfatesanti-inflammatoryatopic dermatitisimmunomodulationmarine polysaccharidered algasulfated galactanλ-carrageenan

Identifiers

PMID41892978
PMCPMC13028040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.